Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Aival
AI-assurance and monitoring for medical imaging AI
Health data & AI platforms
London company building a vendor-neutral QA layer that lets hospitals independently evaluate and continuously monitor the performance, fairness and robustness of third-party medical imaging AI products on local data.
The read
Aival's Analysis Lab, and its Evaluate and Monitor modules, let hospitals independently assess and continuously track the real-world performance, fairness, robustness and explainability of third-party AI products they've deployed, primarily in radiology, rather than trusting a vendor's own validation claims.
The company occupies an unusual meta-layer role in the AI diagnostics market: rather than building diagnostic AI itself, it exists to hold other AI vendors' products accountable once they're live in clinical use, a governance function NHS trusts are increasingly expected to perform under AI-safety guidance.
The Bridgehead view
Aival's positioning as an independent referee for other companies' imaging AI, rather than a competitor to them, is a distinctive PR angle: it can credibly claim to be aligned with hospital and patient interests in a category where most vendors are selling their own AI's accuracy claims.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
The firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
